Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 8

Negative correlation between TNF-α and triglyceride levelsin patients with cerebral infarction

Pages
1583–1588
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The importance of our finding is that it provides useful preliminary information, which is necessary for further research in this field.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To investigate the interactions between tumor necrosis factor-alpha (TNF-α) and blood lipid levels in patients with acute cerebral infarction.Materials and Methods: A total of 43 cerebral infarction patients who applied to the neurology and emergency department of our faculty were included in cross-sectional matched case-control study, and the results were compared with 41 controls who had similar age and comorbidities.
📊
Key Findings & Data:An enzyme-linked immunosorbent test was used to determine baseline plasma TNF-α levels at the time of first admission and potential correlations between the groups were analyzed.Results: Compared to the control group, the cerebral ischemia group had a higher median TNF-α level (23.53; range, 21.74-43.29 ng/L vs. 23.00; range, 20.62-37.34 ng/L); however, the difference was not significant (p > 0.05).
💡
Conclusion & Impact:The importance of our finding is that it provides useful preliminary information, which is necessary for further research in this field.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To investigate the interactions between tumor necrosis factor-alpha (TNF-α) and blood lipid levels in patients with acute cerebral infarction.Materials and Methods: A total of 43 cerebral infarction patients who applied to the neurology and emergency department of our faculty were included in cross-sectional matched case-control study, and the results were compared with 41 controls who had similar age and comorbidities. In addition to fasting serum lipids, serum glucose, C-reactive protein and hemogram were analyzed as well. Classification of infarct was made. An enzyme-linked immunosorbent test was used to determine baseline plasma TNF-α levels at the time of first admission and potential correlations between the groups were analyzed.Results: Compared to the control group, the cerebral ischemia group had a higher median TNF-α level (23.53; range, 21.74-43.29 ng/L vs. 23.00; range, 20.62-37.34 ng/L); however, the difference was not significant (p > 0.05). Groups were similar regarding blood lipid values (p > 0.05). In the patient group, TNF-α level showed a negative correlation with triglyceride (TG) and TG / HDL cholesterol (HDL-C) (rho= -0.319 p= 0.037 and rho= -0.321 p= 0.036), whereas no significant correlation was determined in the control group (p > 0.05), on the other hand plasma level of TNF-α was positively correlated with the National Health Stroke Scale score (rho = 0.455 p = 0.002).Conclusions: Our cross-sectional study revealed an interaction between decreased TG and TG / HDL-C and a high concentration of TNF-α in cerebral infarction for the first time. The importance of our finding is that it provides useful preliminary information, which is necessary for further research in this field.

🔖

Cite This Article

ÇAKIR, M., ÖZCAN, S. S., SAÇMACI, H. (2022). Negative correlation between TNF-α and triglyceride levelsin patients with cerebral infarction. Annals of Medical Research, Cilt: 28 - Sayı: 8, 1583–1588. https://ajindex.com/articles/445908

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Shan Y, Hu J, Lv H, et al. miR-221 Exerts Neuroprotective Effects in Ischemic Stroke by Inhibiting the Proinflammatory Response. J Stroke Cerebrovasc Dis 2021;30:105489
  2. Roth S, Yang J, Cramer JV, et al. Detection of cytokineinduced sickness behavior after ischemic stroke by an optimized behavioral assessment battery. Brain Behav Immun 2021;91:668-72
  3. Maida CD, Norrito RL, Daidone M, et al. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. Int J Mol Sci 2020;21
  4. Postal M, Lapa AT, Sinicato NA, et al. Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus. J Neuroinflammation 2016;13:1-7
  5. Lambertsen KL, Finsen B, Clausen BH. Post-stroke inflammation-target or tool for therapy? Acta Neuropathol 2019;137:693-714
  6. Lin SY, Wang YY, Chang CY, et al. TNF-α Receptor Inhibitor Alleviates Metabolic and Inflammatory Changes in a Rat Model of Ischemic Stroke 2021;10
  7. Pawluk H, Woźniak A, Grześk G. The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke 2020;15:469-84
  8. Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, et al. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol 2019;70
  9. Kloska A, Malinowska M, Gabig-Cimińska M, et al. Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke. Int J Mol Sci 2020;21
  10. Chen X, Xun K, Chen L, et al. TNF-alpha, a potent lipid metabolism regulator. Cell Biochem Funct 2009;27:407-16
  11. Soeki T, Sata M. Inflammatory biomarkers and atherosclerosis. Int Heart J 2016:15-346
  12. Jiang Y, Dai M, Nie WJ, et al. Effects of the ethanol extract of black mulberry (Morus nigra L.) fruit on experimental atherosclerosis in rats. J Ethnopharmacol 2017;200:228-35
  13. Subramani C, Rajakkannu A, Rathinam A, et al. Anti-atherosclerotic activity of root bark of Premna integrifolia Linn. in high fat diet induced atherosclerosis model rats. J Pharm Anal 2017;7:123-8
  14. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008;9:162-76
  15. Wytrykowska A, Prosba-Mackiewicz M, Nyka WM. IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke. J Oral Sci 2016;58:509-13
  16. Hahn BH, Grossman J, Ansell BJ, et al. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lip